aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with cefaclor anhydrous in 1 studies
| Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (cefaclor anhydrous) | Trials (cefaclor anhydrous) | Recent Studies (post-2010) (cefaclor anhydrous) |
|---|---|---|---|---|---|
| 253 | 100 | 17 | 919 | 260 | 92 |
| Protein | Taxonomy | aluminum hydroxide, magnesium hydroxide, drug combination (IC50) | cefaclor anhydrous (IC50) |
|---|---|---|---|
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | 7.184 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerimele, BJ; Coleman, DL; DeSante, KA; Hatcher, BL; Kisicki, J; Satterwhite, JH | 1 |
1 trial(s) available for aluminum hydroxide, magnesium hydroxide, drug combination and cefaclor anhydrous
| Article | Year |
|---|---|
Pharmacokinetics of cefaclor AF: effects of age, antacids and H2-receptor antagonists.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aluminum Hydroxide; Antacids; Biological Availability; Cefaclor; Chemistry, Pharmaceutical; Cimetidine; Drug Combinations; Humans; Intestinal Absorption; Magnesium Hydroxide; Male; Middle Aged; Time Factors | 1992 |